ALPS Advisors’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $340K | Sell |
24,839
-7,923
| -24% | -$109K | ﹤0.01% | 889 |
|
|
2025
Q1 | $362K | Sell |
32,762
-1,359
| -4% | -$15K | ﹤0.01% | 715 |
|
|
2024
Q4 | $363K | Sell |
34,121
-28
| -0.1% | -$298 | ﹤0.01% | 758 |
|
|
2024
Q3 | $434K | Buy |
+34,149
| New | +$434K | ﹤0.01% | 629 |
|
|
2020
Q2 | – | Sell |
-38,139
| Closed | -$680K | – | 831 |
|
|
2020
Q1 | $680K | Sell |
38,139
-4,451
| -10% | -$79.4K | 0.01% | 376 |
|
|
2019
Q4 | $1.42M | Buy |
42,590
+871
| +2% | +$29.1K | 0.01% | 269 |
|
|
2019
Q3 | $994K | Sell |
41,719
-1,740
| -4% | -$41.5K | 0.01% | 313 |
|
|
2019
Q2 | $1.56M | Sell |
43,459
-4,271
| -9% | -$154K | 0.01% | 260 |
|
|
2019
Q1 | $1.76M | Buy |
47,730
+10,520
| +28% | +$389K | 0.01% | 241 |
|
|
2018
Q4 | $1.6M | Buy |
37,210
+9,156
| +33% | +$394K | 0.01% | 243 |
|
|
2018
Q3 | $1.33M | Buy |
28,054
+5,603
| +25% | +$265K | 0.01% | 311 |
|
|
2018
Q2 | $1.12M | Buy |
22,451
+2,045
| +10% | +$102K | 0.01% | 315 |
|
|
2018
Q1 | $1.01M | Buy |
20,406
+5,803
| +40% | +$288K | 0.01% | 312 |
|
|
2017
Q4 | $543K | Buy |
14,603
+2,813
| +24% | +$105K | ﹤0.01% | 474 |
|
|
2017
Q3 | $372K | Buy |
11,790
+984
| +9% | +$31K | ﹤0.01% | 708 |
|
|
2017
Q2 | $195K | Buy |
+10,806
| New | +$195K | ﹤0.01% | 754 |
|